Multiple consortia have been established in the past two decades with the aim of tackling roadblocks in the development of medical products, often by developing new tools to support decision making by ...

In a rapidly changing world, where the speed of technological change exceeds the ability of traditional regulatory systems to adapt, this evolution can no longer be put off. Regulatory simplification ...

A quick regulatory affairs career guide, with advice and resources for beginners, leaders, and everyone in between ...

This content has been selected, created and edited by the Finextra editorial team based upon its relevance and interest to our community. This is an excerpt from a Sibos special edition report: The ...

Medical device manufacturers can face regulatory problems for a variety of reasons, Matthias Kaeser, Principal & Owner at Kaeser Associates, recently told MD+DI. Most of these have to do with ...

Explainer - A new bill would make big changes to how legislation is drafted in New Zealand, but has also drawn considerable criticism as it works its way through Parliament. The Regulatory Standards ...

Amgen Inc. (AMGN) reported strong Q4 2025 results and provided full-year 2026 guidance that was above Street expectations. The company is managing losses of exclusivity on several large products quite ...

Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...